Home/Filings/4/0001737287-25-000076
4//SEC Filing

MESSEMER DEBORAH M. 4

Accession 0001737287-25-000076

CIK 0001737287other

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 9:03 PM ET

Size

5.7 KB

Accession

0001737287-25-000076

Insider Transaction Report

Form 4
Period: 2025-06-18
Transactions
  • Award

    Restricted Stock Unit

    2025-06-18+95,40095,400 total
    Common Stock (95,400 underlying)
Footnotes (1)
  • [F1]Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. Ms. Messemer has elected to defer the receipt of Common Stock upon the vesting of her RSUs pursuant to the Companys Non-Employee Director Compensation Policy until the earlier of (i) 30 days following separation from the Board or (ii) a change in control of the Company.

Issuer

Allogene Therapeutics, Inc.

CIK 0001737287

Entity typeother

Related Parties

1
  • filerCIK 0001754424

Filing Metadata

Form type
4
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 9:03 PM ET
Size
5.7 KB